Cisplatin‐induced oxPAPC release enhances MDSCs infiltration into LL2 tumour tissues through MCP‐1/CCL2 and LTB4/LTB4R pathways

Lack of SIRP ‐alpha reduces lung cancer growth in mice by promoting anti‐tumour ability of macrophages and neutrophils

(2022) Linyue Pan et al.   CELL PROLIFERATION

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting

(2021) Maosen Xu et al.   CELL PROLIFERATION

Cisplatin induces lung cell cilia disruption and lung damage via oxidative stress

(2021) Yong Kwon Han et al.   FREE RADICAL BIOLOGY AND MEDICINE

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

(2020) Charles M. Rudin et al.   JOURNAL OF CLINICAL ONCOLOGY

The innate immune architecture of lung tumors and its implication in disease progression

(2019) Simon Milette et al.   JOURNAL OF PATHOLOGY

IL-10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF-κB/Notch1 pathway in non-small cell lung cancer

(2019) Li Yang et al.   INTERNATIONAL JOURNAL OF CANCER

Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition

(2019) Alberto Cruz-Bermúdez et al.   FREE RADICAL BIOLOGY AND MEDICINE

A Novel Paradigm Between Leukocytosis, G-CSF Secretion, Neutrophil-to-Lymphocyte Ratio, Myeloid-Derived Suppressor Cells, and Prognosis in Non-small Cell Lung Cancer

(2019) Montreh Tavakkoli et al.   Frontiers in Oncology

Cisplatin: The first metal based anticancer drug

(2019) Sumit Ghosh   BIOORGANIC CHEMISTRY

The Tumor Microenvironment Innately Modulates Cancer Progression

(2019) Dominique C. Hinshaw et al.   CANCER RESEARCH

Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor

(2019) Bao-Hua Li et al.   MOLECULAR IMMUNOLOGY

Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-small-cell Lung Cancer

(2018) Yoshikane Yamauchi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Myeloid Regulatory Cells - New and Exciting Players in the Immunology of Lung Cancer

(2018) Zvi G Fridlender   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?

(2018) Teizo Yoshimura   Cellular & Molecular Immunology

Cancer related circulating and tumor-associated neutrophils - subtypes, sources and function

(2018) Merav E. Shaul et al.   FEBS Journal

Mitochondrial NADP+-dependent isocitrate dehydrogenase deficiency increases cisplatin-induced oxidative damage in the kidney tubule cells

(2018) Min Jung Kong et al.   Cell Death & Disease

Fragmentation of kidney epithelial cell primary cilia occurs by cisplatin and these cilia fragments are excreted into the urine

(2018) Min Jung Kong et al.   Redox Biology

The role of stromal cancer-associated fibroblasts in pancreatic cancer

(2017) Dagny von Ahrens et al.   Journal of Hematology & Oncology

CCL2/CCR2 signaling pathway in glioblastoma multiforme

(2017) Alireza Vakilian et al.   NEUROCHEMISTRY INTERNATIONAL

The yin and yang of leukotriene B 4 mediated inflammation in cancer

(2017) Venkatakrishna R. Jala et al.   SEMINARS IN IMMUNOLOGY

Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration

(2017) Annie Tosello-Trampont et al.   Frontiers in Immunology

Impact of Metabolism in on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment

(2017) Soumaya Kouidhi et al.   Frontiers in Immunology

Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity

(2017) Xenia Geeraerts et al.   Frontiers in Immunology

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study

(2016) Susanna Mandruzzato et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Implications of MDSCs-targeting in lung cancer chemo-immunotherapeutics

(2016) Dickson Adah et al.   PHARMACOLOGICAL RESEARCH

The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis

(2016) W. Liang et al.   Cancer Immunology Research

Systemic Chemotherapy Is Modulated by Platelet-Activating Factor-Receptor Agonists

(2015) Ravi P. Sahu et al.   MEDIATORS OF INFLAMMATION

Iron and Neurodegeneration: Is Ferritinophagy the Link?

(2015) Giorgio Biasiotto et al.   MOLECULAR NEUROBIOLOGY

Neutrophils in Cancer: Two Sides of the Same Coin

(2015) Eileen Uribe-Querol et al.   Journal of Immunology Research

Galectin-3 contributes to cisplatin-induced myeloid derived suppressor cells (MDSCs) recruitment in Lewis lung cancer-bearing mice

(2014) Tian Wang et al.   MOLECULAR BIOLOGY REPORTS

Cigarette Smoke Exposure Inhibits Contact Hypersensitivity via the Generation of Platelet-Activating Factor Agonists

(2013) R. P. Sahu et al.   JOURNAL OF IMMUNOLOGY

The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists

(2012) Ravi P. Sahu et al.   CARCINOGENESIS

Drug resistance and its significance for treatment decisions in non-small-cell lung cancer

(2012) G.D. Goss et al.   Current Oncology

A simplified procedure for semi-targeted lipidomic analysis of oxidized phosphatidylcholines induced by UVA irradiation

(2012) Florian Gruber et al.   JOURNAL OF LIPID RESEARCH

Origins of tumor-associated macrophages and neutrophils

(2012) V. Cortez-Retamozo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13

(2011) Rachel F. Gabitass et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Complement factor H binds malondialdehyde epitopes and protects from oxidative stress

(2011) David Weismann et al.   NATURE

Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes

(2010) K. Movahedi et al.   CANCER RESEARCH

Inflammation 2010: New Adventures of an Old Flame

(2010) Ruslan Medzhitov   CELL

Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

(2010) Thomas Condamine et al.   TRENDS IN IMMUNOLOGY

The involvement of transition metal ions on iron-dependent lipid peroxidation

(2009) Marisa G. Repetto et al.   ARCHIVES OF TOXICOLOGY

Multiple Myeloma Bone Marrow Niche

(2009) Grzegorz Basak et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

(2008) K. Movahedi et al.   BLOOD

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

(2008) C. Marcela Diaz-Montero et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury

(2008) Yumiko Imai et al.   CELL

Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy

(2008) Daniel Cruz et al.   JOURNAL OF CLINICAL INVESTIGATION